新聞Janssen Pharmaceuticals, Inc. sold assets to Depomed, Inc. on Apr 1st '17.Janssen Pharmaceutical sold its license of marketing and distribution of the U.S. to Depomed, Inc. and in April 2017, Depomed, Inc. won the patent for tapentadol.
新聞Depomed, Inc. hired John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications on Apr 17th '18.Depomed, Inc. (NASDAQ: DEPO ) today announced the appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications, effective immediately.
新聞Depomed, Inc. hired Stan Bukofzer as Senior Vice President, Chief Medical and Scientific Officer on Apr 2nd '18.Depomed has hired Stan Bukofzer, M.D., an Abbott veteran who also served in VP spots at Astellas and Hospira, as its senior vice president and chief medical and scientific officer.
